National Health Investors Inc (NHI) Expected to Post Quarterly Sales of $71.36 Million

Wall Street brokerages expect National Health Investors Inc (NYSE:NHI) to post sales of $71.36 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for National Health Investors’ earnings. The lowest sales estimate is $70.90 million and the highest is $71.83 million. National Health Investors posted sales of $64.69 million during the same quarter last year, which indicates a positive year-over-year growth rate of 10.3%. The firm is expected to issue its next earnings results on Friday, February 16th.

According to Zacks, analysts expect that National Health Investors will report full year sales of $71.36 million for the current financial year, with estimates ranging from $275.00 million to $279.03 million. For the next year, analysts expect that the business will report sales of $300.42 million per share, with estimates ranging from $298.19 million to $303.08 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow National Health Investors.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, November 8th. The real estate investment trust reported $0.94 earnings per share for the quarter, missing analysts’ consensus estimates of $1.34 by ($0.40). National Health Investors had a net margin of 59.70% and a return on equity of 12.74%.

A number of research firms have recently weighed in on NHI. KeyCorp reiterated an “underweight” rating on shares of National Health Investors in a research report on Tuesday, December 19th. Stephens set a $79.00 price target on National Health Investors and gave the stock a “buy” rating in a report on Friday, January 12th. BMO Capital Markets reissued a “hold” rating and set a $80.00 price target on shares of National Health Investors in a report on Wednesday, October 18th. Cantor Fitzgerald reissued a “hold” rating and set a $85.00 price target on shares of National Health Investors in a report on Wednesday, January 17th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $82.00 price target on shares of National Health Investors in a report on Wednesday, October 4th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. National Health Investors currently has an average rating of “Hold” and an average target price of $81.25.

Institutional investors have recently bought and sold shares of the company. Legal & General Group Plc raised its holdings in shares of National Health Investors by 13.9% during the 3rd quarter. Legal & General Group Plc now owns 116,146 shares of the real estate investment trust’s stock worth $8,980,000 after buying an additional 14,142 shares in the last quarter. Prudential Financial Inc. increased its holdings in National Health Investors by 137.4% in the 2nd quarter. Prudential Financial Inc. now owns 13,683 shares of the real estate investment trust’s stock worth $1,084,000 after purchasing an additional 7,920 shares in the last quarter. Dupont Capital Management Corp acquired a new position in National Health Investors in the 3rd quarter worth about $2,087,000. First Trust Advisors LP increased its holdings in National Health Investors by 29.8% in the 3rd quarter. First Trust Advisors LP now owns 99,856 shares of the real estate investment trust’s stock worth $7,718,000 after purchasing an additional 22,938 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in National Health Investors by 57.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock worth $30,514,000 after purchasing an additional 144,650 shares in the last quarter. 70.12% of the stock is owned by institutional investors.

Shares of National Health Investors (NYSE:NHI) opened at $69.80 on Monday. The firm has a market capitalization of $2,898.94, a price-to-earnings ratio of 17.45, a PEG ratio of 3.22 and a beta of 0.59. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a 1 year low of $68.96 and a 1 year high of $81.60.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be issued a dividend of $0.95 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 5.44%. National Health Investors’s dividend payout ratio (DPR) is currently 95.00%.

COPYRIGHT VIOLATION NOTICE: This news story was posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/22/national-health-investors-inc-nhi-expected-to-post-quarterly-sales-of-71-36-million-2.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply